Patent Assignment
Reel/Frame 065968/0293
Confirmatory License
Recorded: 2023-12-13
Pages: 2
Assignor
FRED HUTCHINSON CANCER RESEARCH CENTER
Executed: 2021-10-15
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Cancer Combination Therapies Utilizing a Nicotinamide Phosphoribosyltransferase Inhibitor in Combination with a Nicotinamide Adenine Dinucleotide Salvage Pathway Precursor
Application:
17/441,599 →
Publication:
US 2022/0125814
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 22, 2021
From: HOCKENBERY, DAVID M.; PADDISON, PATRICK
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 057566/0672 →
Merger and Change of Name
Jun 23, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060439/0279 →
Corrective Assignment to Correct the Patent Application Number 63/242,906 Previously Recorded on Reel 060439 Frame 0279. Assignor(S) Hereby Confirms the Merger and Change of Name.
Nov 4, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 061847/0594 →
Merger and Change of Name
May 18, 2026
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 074681/0643 →